Audit of 1 year survival for patients receiving chemotherapy for NSCLC - all comers

被引：0
|
作者：
Allison, J. L. E. [1 ]
Lord, H. [2 ]
机构：
[1] NHS Tayside, Med Oncol, Dundee, Scotland
[2] Univ Dundee, Ninewells Hosp & Med Sch, NHS Tayside, Oncol, Dundee DD1 9SY, Scotland
来源：
LUNG CANCER | 2016年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
81
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [1] An audit of SCLC patients not receiving chemotherapy
    Morris, J.
    Woolnough, K.
    Sheldon, J.
    Nanda, U.
    Beckett, P.
    LUNG CANCER, 2009, 63 : S10 - S10
  • [2] Association of Sarcopenia with Survival in Advanced NSCLC Patients Receiving Concurrent Immunotherapy and Chemotherapy
    Bolte, F. J.
    McTavish, S.
    Wakefield, N.
    Shantzer, L.
    Hubbard, C.
    Krishnaraj, A.
    Novicoff, W.
    Hall, R.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S353 - S353
  • [3] Association of sarcopenia with survival in advanced NSCLC patients receiving concurrent immunotherapy and chemotherapy
    Bolte, Fabian J. J.
    McTavish, Sloane
    Wakefield, Nathan
    Shantzer, Lindsey
    Hubbard, Caroline
    Krishnaraj, Arun
    Novicoff, Wendy
    Gentzler, Ryan D. D.
    Hall, Richard D. D.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] What are the commonest toxicities for patients receiving chemotherapy for NSCLC? - a look at 6 months of data for all corners
    Allison, J. L. E.
    Lord, H.
    LUNG CANCER, 2016, 91 : S30 - S31
  • [5] Improving survival for NSCLC patients in the national lung cancer audit
    Beckett, Paul
    Woolhouse, Ian
    Peake, Mick
    Tata, Laila
    Khakwani, Aamir
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [6] NQO1*2 genotype predicts poor survival in NSCLC patients receiving radiation and chemotherapy as part of E3590
    Kolesar, J
    Vangel, M
    McLeod, H
    Schiller, J
    Johnson, D
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S43 - S43
  • [7] The Effectiveness of RECIST on Survival in Patients with NSCLC Receiving Chemotherapy with or without Target Agents as First-Line Treatment
    Zhou, Ting
    Zheng, Lie
    Hu, Zhihuang
    Zhang, Yang
    Fang, Wenfeng
    Zhao, Yuanyuan
    Ge, Jieying
    Zhao, Hongyun
    Zhang, Li
    SCIENTIFIC REPORTS, 2015, 5
  • [8] The Effectiveness of RECIST on Survival in Patients with NSCLC Receiving Chemotherapy with or without Target Agents as First-Line Treatment
    Ting Zhou
    Lie Zheng
    Zhihuang Hu
    Yang Zhang
    Wenfeng Fang
    Yuanyuan Zhao
    Jieying Ge
    Hongyun Zhao
    Li Zhang
    Scientific Reports, 5
  • [9] Quality of life and survival in patients receiving chemotherapy for advanced non-small cell lung cancer (NSCLC)
    St-Pierre, D. M.
    Kreisman, H.
    Kasymjanova, G.
    Agulnik, J. S.
    Swanson, T.
    Pepe, C.
    Lajeunesse, L.
    Gagne, S.
    Dajczman, E.
    Pereira, L.
    Small, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Nephrotoxicity in Patients with Advanced NSCLC Receiving Pemetrexed-Based Chemotherapy
    Visser, Sabine
    Huisbrink, Jeannine
    Van Toor, Jermo
    Van Walree, Nico
    Stricker, Bruno
    Aerts, Joachim
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S894 - S895
12345